The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability. / la Cour, Jonas; Høj, Berit Rahbek; Mollerup, Jens; Simon, Ronald; Sauter, Guido; Berchtold, Martin Werner.
I: Molecular Oncology, Bind 1, Nr. 4, 2008, s. 431-439.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability
AU - la Cour, Jonas
AU - Høj, Berit Rahbek
AU - Mollerup, Jens
AU - Simon, Ronald
AU - Sauter, Guido
AU - Berchtold, Martin Werner
N1 - Keywords: Calcium binding proteins, Tissue microarray, Gene silencing, ALG-2
PY - 2008
Y1 - 2008
N2 - The apoptosis linked gene-2 (ALG-2), discovered as a proapoptotic calcium binding protein, has recently been found upregulated in lung cancer tissue indicating that this protein may play a role in the pathology of cancer cells and/or may be a tumor marker. Using immunohistochemistry on tissue microarrays we analysed the expression of ALG-2 in 7371 tumor tissue samples of various origin as well as in 749 normal tissue samples. Most notably, ALG-2 was upregulated in mesenchymal tumors. No correlation was found between ALG-2 staining intensity and survival of patients with lung, breast or colon cancer. siRNA mediated ALG-2 downregulation led to a significant reduction in viability of HeLa cells indicating that ALG-2 may contribute to tumor development and expansion.
AB - The apoptosis linked gene-2 (ALG-2), discovered as a proapoptotic calcium binding protein, has recently been found upregulated in lung cancer tissue indicating that this protein may play a role in the pathology of cancer cells and/or may be a tumor marker. Using immunohistochemistry on tissue microarrays we analysed the expression of ALG-2 in 7371 tumor tissue samples of various origin as well as in 749 normal tissue samples. Most notably, ALG-2 was upregulated in mesenchymal tumors. No correlation was found between ALG-2 staining intensity and survival of patients with lung, breast or colon cancer. siRNA mediated ALG-2 downregulation led to a significant reduction in viability of HeLa cells indicating that ALG-2 may contribute to tumor development and expansion.
U2 - 10.1016/j.molonc.2007.08.002
DO - 10.1016/j.molonc.2007.08.002
M3 - Journal article
C2 - 19383317
VL - 1
SP - 431
EP - 439
JO - Molecular Oncology
JF - Molecular Oncology
SN - 1574-7891
IS - 4
ER -
ID: 9590196